Literature DB >> 21620663

Thrombectomy and surgical reconstruction for extensive iliocaval thrombosis in a patient with agenesis of the retrohepatic vena cava and atresia of the left renal vein.

Michele La Spada1, Francesco Stilo, Giuseppe Carella, Ignazio Salomone, Filippo Benedetto, Giovanni De Caridi, Francesco Spinelli.   

Abstract

In 80% of the patients presenting with deep-venous thrombosis (DVT), a risk factor can be identified. An absent or hypoplastic infrarenal vena cava is a rare risk factor for DVT in young adults. In these cases, the prevalence of congenital anomalies of the inferior vena cava (IVC) is estimated at 0.5% of the general population, up to 5% in young people. The association with coagulopathy increases the risk of DVT. We report a case of a young man who presented with a massive caval and iliofemoral-popliteal thrombosis in presence of the agenesis of retrohepatic inferior vena cava and atresia of the left renal vein. Open thrombectomy and caval reconstruction with a polytetrafluoroethylene graft were performed. Surgical option with vein reconstruction was preferred to prevent new episodes of thrombosis and the risk of acute renal failure.
Copyright © 2011 Annals of Vascular Surgery Inc. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21620663     DOI: 10.1016/j.avsg.2010.12.038

Source DB:  PubMed          Journal:  Ann Vasc Surg        ISSN: 0890-5096            Impact factor:   1.466


  2 in total

1.  Elevated risk of thrombophilia in agenesis of the vena cava as a factor for deep vein thrombosis.

Authors:  Tolga Atilla Sagban; Rüdiger E Scharf; Markus U Wagenhäuser; Alexander Oberhuber; Hubert Schelzig; Klaus Grabitz; Mansur Duran
Journal:  Orphanet J Rare Dis       Date:  2015-01-21       Impact factor: 4.123

2.  Extensive deep venous thrombosis in a young male with absent infrarenal inferior vena cava.

Authors:  Michael Jiang; Timothy C Lai; David Mitchell; Liang G Qu
Journal:  J Vasc Surg Cases Innov Tech       Date:  2022-01-26
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.